What is the Amniotic Membrane Injection procedure?
Amniotic membrane extract is obtained from placental membranes after routine C-section from healthy, pre-screened pregnant donors. There are no ethical issues associated with harvesting amniotic tissue since they are derived from placentas destined for bio-waste disposal. This extract contains potent, concentrated growth factors, cytokines, and extracellular matrix upon which host stem cells or other beneficial blood tissue components can implant upon and multiply.
Amniotic Membrane Extracts(AME)
The challenge in procuring sterile, high quality tissue lies in finding a source that can meet our standards and consistently offers high quality processing techniques.
When choosing an additive to enhance PRP injections, we use high-quality amniotic tissue extracts from proven providers in the U.S., certified to use Good Manufacturing Practices. Their methodology results in high quality tissue that combines collagen and other structural proteins to create a scaffold, so to speak, to which donor tissue and recipient stem cells can adhere, keeping them in place.
AME is obtained from
Live, elective donors who are carefully screened to ensure that they are healthy
Products that only meet FDA, 21 CFR 1271, Section 361 criteria
Patented Cryo-Preservation technology that ensfures immediate strorage at optimal temperatures
Patented processing technology
Procurement and processing centers are AATBf certified and FDA regulated
To date, there are no reported case reports of communicable disease or unwanted tissue growth/cancer from amniotic membrane extract.
